AMAG Pharmaceuticals
AMAG
AMAG was delisted on the 13th of November, 2020.
119 hedge funds and large institutions have $244M invested in AMAG Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 41 reducing their positions, and 26 closing their positions.
2% less call options, than puts
Call options by funds: $1.69M | Put options by funds: $1.73M
5% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 41
11% less funds holding
Funds holding: 134 → 119 (-15)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
52% less capital invested
Capital invested by funds: $508M → $244M (-$264M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.65M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.57M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.14M |
| 4 |
BlackRock
New York
|
+$1.04M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$952K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.98M |
| 2 |
Morgan Stanley
New York
|
-$4.39M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$2.79M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.7M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$2.39M |
AMAG Hedge Fund Activity: Q1 2020 in Review
119 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q1 2020, worth a combined $244M — down 52% from $508M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AMAG and 13 opened new positions — a net loss of 13 holders — while 41 trimmed existing stakes and 39 added.
The largest buyer was Vanguard Group, adding an estimated $2.65M. The largest seller was Millennium Management, exiting entirely with an estimated $5.98M sold.
- 119 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q1 2020, down from 134 in Q4 2019.
- Funds reported $244M of AMAG Pharmaceuticals stock for Q1 2020, down 52% quarter-over-quarter.
- 13 funds opened new AMAG Pharmaceuticals positions in Q1 2020 and 26 closed out, a net change of -13 holders.
- The largest AMAG Pharmaceuticals buyer in Q1 2020 was Vanguard Group, an estimated $2.65M added.
- The largest AMAG Pharmaceuticals seller in Q1 2020 was Millennium Management, an estimated $5.98M sold.
Based on aggregated 13F filings for Q1 2020.